Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00249587 · ClinicalTrials.gov registry record · Phase 1
Medication Adherence Therapy for Opioid Abusing Pain Patients
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT00249587 is a Phase 1 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 36 participants.
The verdict
NCT00249587, a Phase 1 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and pilot test a combined behavioral and pharmacological intervention designed to decrease pain, functional interference, and drug abuse while increasing medication adherence.
Interventions
- DRUG Methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2000-09 |
| Est. Completion | 2005-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00249587
The ClinicalTrials.gov registry entry for NCT00249587 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methadone is the first listed.
NCT00249587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00249587 about?
NCT00249587 is a clinical study titled "Medication Adherence Therapy for Opioid Abusing Pain Patients". The purpose of this study is to develop and pilot test a combined behavioral and pharmacological intervention designed to decrease pain, functional interference, and drug abuse while increasing medication adherence.
What is the current status of trial NCT00249587?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2000-09. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00249587?
The interventions under investigation include: Methadone (DRUG).
Who is sponsoring clinical trial NCT00249587?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.